D. Ferry
Eli Lilly (United States) · 110 works · 5,056 citations · h-index 35
Top works
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
- Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
- [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
- Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
- Clinical trials of p-glycoprotein reversal in solid tumours
- Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonists
- Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4‐dihydropyridine photoaffinity probe, [3H]azidopine.
- Target size analysis of skeletal muscle Ca2+ channels
- A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
- Molecular Pharmacology of the Calcium Channel
- [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface
- Calcium channels: evidence for oligomeric nature by target size analysis.
- ACTH precursors characterize the ectopic ACTH syndrome
- Pulmonary metastasectomy in colorectal cancer: Time for a trial
- (—)‐[3H]Desmethoxyverapamil, a novel Ca2+ channel probe
- Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin
- Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
- Determination of quercetin in human plasma by HPLC with spectrophotometric or electrochemical detection